IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2090-5920

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy ; volume:19 ; number:1 ; day:8 ; month:10 ; year:2021 ; pages:1-10 ; date:12.2021
Journal of Genetic Engineering and Biotechnology ; 19, Heft 1 (8.10.2021), 1-10, 12.2021

Creator: Attallah, Abdelfattah M.
Omran, Dalia
Abdelrazek, Mohamed A.
Hassany, Mohamed
Saif, Sameh
Farid, Aza
Essawey, Riham El
Ghaffar, Muhammad Abdel
Aabdelghany, Marwa
Yosry, Ayman

Contributor: SpringerLink (Online service)

DOI: 10.1186/s43141-021-00250-y

URN: urn:nbn:de:101:1-2021122507281223968960

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:22 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Attallah, Abdelfattah M.
Omran, Dalia
Abdelrazek, Mohamed A.
Hassany, Mohamed
Saif, Sameh
Farid, Aza
Essawey, Riham El
Ghaffar, Muhammad Abdel
Aabdelghany, Marwa
Yosry, Ayman
SpringerLink (Online service)

Other Objects (12)

Effect of immunogenetics polymorphism and expression on direct-acting antiviral drug response in chronic hepatitis C

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era

Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis

Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study

HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)

Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C

Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study

Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents

Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents

Effect of immunogenetics polymorphism and expression on direct-acting antiviral drug response in chronic hepatitis C

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era

Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis

Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study

HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)

Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C

Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study

Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents

Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents

Effect of immunogenetics polymorphism and expression on direct-acting antiviral drug response in chronic hepatitis C

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era

Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis

Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study

HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)

Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C

Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study

Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents

Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Effect of immunogenetics polymorphism and expression on direct-acting antiviral drug response in chronic hepatitis C

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era

Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis

Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study

HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)

Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C

Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study

Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents

Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents

Effect of immunogenetics polymorphism and expression on direct-acting antiviral drug response in chronic hepatitis C

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era

Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis

Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study

HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)

Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C

Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study

Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents

Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents

Effect of immunogenetics polymorphism and expression on direct-acting antiviral drug response in chronic hepatitis C

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era

Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis

Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study

HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)

Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C

Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study

Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents

Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents

Related objects

Reset password